NCT06998407
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06998407
Title Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Avenzo Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Avenzo Therapeutics Recruiting Site RECRUITING Los Angeles California 90095 United States Details
Avenzo Therapeutics Recruiting Site NOT_YET_RECRUITING New Haven Connecticut 06519 United States Details
Avenzo Therapeutics Recruiting Site NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
Avenzo Therapeutics Recruiting Site NOT_YET_RECRUITING New York New York 10016 United States Details
Avenzo Therapeutics Recruiting Site NOT_YET_RECRUITING Cleveland Ohio 44106 United States Details
Avenzo Therapeutics Recruiting Site NOT_YET_RECRUITING Houston Texas 77030 United States Details
Avenzo Therapeutics Recruiting Site RECRUITING San Antonio Texas 78229 United States Details
Avenzo Therapeutics Recruiting Site RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field